Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-10 ل  4,848 نتائج ل ""Tenofovir""

فلترة النتائج

Subject : hiv infections
إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Health care providers' decision-making and early adoption of tenofovir alafenamide for HIV preexposure prophylaxis: An inductive qualitative study.

  • Authors : Merchant E; Department of Medicine, Tufts Medical Center, Boston, MA, United States of America.; Tufts University School of Medicine, Boston, MA, United States of America.

Subjects: Tenofovir*/Tenofovir*/Tenofovir*/administration & dosage ; Tenofovir*/Tenofovir*/Tenofovir*/therapeutic use ; Tenofovir*/Tenofovir*/Tenofovir*/analogs & derivatives

  • Source: PloS one [PLoS One] 2024 Dec 05; Vol. 19 (12), pp. e0311591. Date of Electronic Publication: 2024 Dec 05 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Assessment of risk factors for virological nonsuppression following switch to dolutegravir and lamivudine, or bictegravir, emtricitabine, and tenofovir alafenamide fumarate in a real-world cohort of treatment-experienced adults living with HIV.

  • Authors : Lee SY; Department of Infectious Diseases, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan City, Taiwan.; Lin YC

Subjects: HIV Infections*/HIV Infections*/HIV Infections*/drug therapy ; HIV Infections*/HIV Infections*/HIV Infections*/virology ; Pyridones*/Pyridones*/Pyridones*/therapeutic use

  • Source: PloS one [PLoS One] 2024 Nov 20; Vol. 19 (11), pp. e0314003. Date of Electronic Publication: 2024 Nov 20 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

In-utero exposure to tenofovir-containing pre-exposure prophylaxis and bone mineral content in HIV-unexposed infants in South Africa.

  • Authors : Reddy K; Department of Paediatrics and Child Health, School of Clinical Medicine, University of KwaZulu Natal, Durban, South Africa.; Naidoo KL

Subjects: Tenofovir*/Tenofovir*/Tenofovir*/therapeutic use ; Tenofovir*/Tenofovir*/Tenofovir*/administration & dosage ; Tenofovir*/Tenofovir*/Tenofovir*/adverse effects

  • Source: Journal of the International AIDS Society [J Int AIDS Soc] 2024 Nov; Vol. 27 (11), pp. e26379.Publisher: John Wiley & Sons, Inc Country of Publication: Switzerland NLM ID: 101478566 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Risk of dyslipidaemia in people living with HIV who are taking tenofovir alafenamide: a systematic review and meta-analysis.

  • Authors : Yoo JJ; Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Republic of Korea.; Jung EA

Subjects: HIV Infections*/HIV Infections*/HIV Infections*/drug therapy ; Tenofovir*/Tenofovir*/Tenofovir*/therapeutic use ; Tenofovir*/Tenofovir*/Tenofovir*/adverse effects

  • Source: Journal of the International AIDS Society [J Int AIDS Soc] 2024 Sep; Vol. 27 (9), pp. e26358.Publisher: John Wiley & Sons, Inc Country of Publication: Switzerland NLM ID: 101478566 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Metabolic, Mitochondrial, and Inflammatory Effects of Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate in Asymptomatic Antiretroviral-Naïve People with HIV.

  • Authors : Barroso S; Inherited Metabolic Diseases and Muscular Disorders Research Lab, Cellex-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Faculty of Medicine and Health Sciences, University of Barcelona (UB), 08036 Barcelona, Spain.; Department of Internal Medicine, Hospital Clinic of Barcelona, 08036 Barcelona, Spain.

Subjects: HIV Infections*/HIV Infections*/HIV Infections*/drug therapy ; HIV Infections*/HIV Infections*/HIV Infections*/metabolism ; Mitochondria*/Mitochondria*/Mitochondria*/metabolism

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Aug 01; Vol. 25 (15). Date of Electronic Publication: 2024 Aug 01.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

HIV-1 pretreatment and acquired antiretroviral drug resistance before tenofovir/ /lamivudine /dolutegravir (TLD) roll-out in Mozambique.

  • Authors : Ismael N; Instituto Nacional de Saúde, EN1, Bairro da Vila - Parcela N˚3943, Marracuene Sede, Marracuene, Maputo Province, Mozambique. .; Division of Medical Virology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa. .

Subjects: HIV Infections*/HIV Infections*/HIV Infections*/drug therapy ; HIV Infections*/HIV Infections*/HIV Infections*/virology ; Drug Resistance, Viral*/Drug Resistance, Viral*/Drug Resistance, Viral*/genetics

  • Source: BMC infectious diseases [BMC Infect Dis] 2024 Jul 29; Vol. 24 (1), pp. 748. Date of Electronic Publication: 2024 Jul 29.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Renal safety of tenofovir alafenamide-based antiretroviral therapy in people with HIV: A mini-review.

  • Authors : Zhao F; National Clinical Research Centre for Infectious Diseases, The Third People's Hospital of Shenzhen and The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen, Guangdong, China.; Lu H

Subjects: Tenofovir*/Tenofovir*/Tenofovir*/adverse effects ; Tenofovir*/Tenofovir*/Tenofovir*/therapeutic use ; Tenofovir*/Tenofovir*/Tenofovir*/analogs & derivatives

  • Source: Bioscience trends [Biosci Trends] 2024 Jun 06; Vol. 18 (2), pp. 141-152. Date of Electronic Publication: 2024 Apr 24.Publisher: International Research and Cooperation Association for Bio & Socio-Sciences Advancement Country of Publication: Japan NLM ID: 101502754 Publication

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Pharmacokinetics of tenofovir alafenamide, emtricitabine, and dolutegravir in a patient on peritoneal dialysis.

  • Authors : Massih SA; Division of Clinical Pharmacology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Atta MG

Subjects: Heterocyclic Compounds, 3-Ring*/Heterocyclic Compounds, 3-Ring*/Heterocyclic Compounds, 3-Ring*/pharmacokinetics ; Heterocyclic Compounds, 3-Ring*/Heterocyclic Compounds, 3-Ring*/Heterocyclic Compounds, 3-Ring*/therapeutic use ; Heterocyclic Compounds, 3-Ring*/Heterocyclic Compounds, 3-Ring*/Heterocyclic Compounds, 3-Ring*/adverse effects

  • Source: AIDS research and therapy [AIDS Res Ther] 2024 May 21; Vol. 21 (1), pp. 34. Date of Electronic Publication: 2024 May 21.Publisher: BioMed Central Country of Publication: England NLM ID: 101237921 Publication Model: Electronic Cited Medium: Internet ISSN: 1742-6405

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Urine tenofovir testing for real-time PrEP adherence feedback: a qualitative study involving transgender women in Uganda.

  • Authors : Mujugira A; The Infectious Diseases Institute Limited, Makerere University, Kampala, Uganda.; Department of Global Health, University of Washington, Seattle, Washington, USA.

Subjects: Tenofovir*/Tenofovir*/Tenofovir*/urine ; Tenofovir*/Tenofovir*/Tenofovir*/therapeutic use ; Pre-Exposure Prophylaxis*/Pre-Exposure Prophylaxis*/Pre-Exposure Prophylaxis*/methods

  • Source: Journal of the International AIDS Society [J Int AIDS Soc] 2024 May; Vol. 27 (5), pp. e26255.Publisher: John Wiley & Sons, Inc Country of Publication: Switzerland NLM ID: 101478566 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Urinary α 1-microglobulin and β 2-microglobulin as markers of early kidney injury in HIV-positive male patients on tenofovir-based antiretroviral therapy.

  • Authors : Yu XL; The Fourth Department of Infectious Diseases, Wuhan Jinyintan Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.; Hubei Clinical Research Center for Infectious Diseases, Wuhan, China.

Subjects: beta 2-Microglobulin*/beta 2-Microglobulin*/beta 2-Microglobulin*/urine ; Alpha-Globulins*/Alpha-Globulins*/Alpha-Globulins*/urine ; Tenofovir*/Tenofovir*/Tenofovir*/therapeutic use

  • Source: PloS one [PLoS One] 2024 Jun 17; Vol. 19 (6), pp. e0303442. Date of Electronic Publication: 2024 Jun 17 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
  • 1-10 ل  4,848 نتائج ل ""Tenofovir""